MAR 09, 2021 1:31 AM PST

Leprosy Drug Repurposed for Potential COVID19 Treatment

WRITTEN BY: Nouran Amin

New research published in Nature study shows that a drug for treating leprosy was repurposed to treat COVID19.

The study found that the leprosy drug, known as clofazimine, holds antiviral properties against SARS-CoV-2 and thus preventing sever COVID19 inflammatory responses.

"Clofazimine is an ideal candidate for a COVID-19 treatment. It is safe, affordable, easy to make, taken as a pill and can be made globally available," says co-senior author Sumit Chanda, Ph.D., professor and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. "We hope to test clofazimine in a Phase 2 clinical trial as soon as possible for people who test positive for COVID-19 but are not hospitalized. Since there is currently no outpatient treatment available for these individuals, clofazimine may help reduce the impact of the disease, which is particularly important now as we see new variants of the virus emerge and against which the current vaccines appear less efficacious."

Learn more about the mechanism of action:

"The animals that received clofazimine had less lung damage and lower viral load, especially when receiving the drug before infection," says co-senior author Ren Sun, Ph.D., professor at the University of Hong Kong and distinguished professor emeritus at the University of California, Los Angeles (UCLA). "Besides inhibiting the virus, there are indications that the drug also regulates the host response to the virus, which provides better control of the infection and inflammation."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 16, 2022
Neuroscience
A New Approach to Seizure Treatment
APR 16, 2022
A New Approach to Seizure Treatment
There are many types of epilepsy, a brain disorder that causes recurrent seizures or periods of altered behaviors or sen ...
APR 21, 2022
Cannabis Sciences
One of the most lucrative skillsets in cannabis
APR 21, 2022
One of the most lucrative skillsets in cannabis
For anyone looking for a well-compensated, in demand job in the cannabis industry, you can't go wrong with becoming an e ...
APR 22, 2022
Health & Medicine
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
APR 22, 2022
Differences in the Impact of Acute and Chronic Cannabis Use on Stress Response Regulation
A new study published in Frontiers examined the influence of acute and chronic cannabis use on stress regulation. Althou ...
MAY 07, 2022
Drug Discovery & Development
Ibuprofen and Blood Pressure Medication Linked to Kidney Damage
MAY 07, 2022
Ibuprofen and Blood Pressure Medication Linked to Kidney Damage
A combination of ibuprofen and certain blood pressure medications could lead to acute kidney injury. The corresponding s ...
JUN 14, 2022
Cancer
Maintaining Sample Temperature: Q&A From a Corning Scientist
JUN 14, 2022
Maintaining Sample Temperature: Q&A From a Corning Scientist
Generally speaking, bad things can happen when a cell sample temperature gets too hot or too cold. Temperature instabili ...
JUN 10, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUN 10, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
Loading Comments...